• $1,826.00
    Market Cap
  • -99.00%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
745,093
-28.76%
1.0M
N/A
Cost of Revenue
477,430
-16.01%
568,409
N/A
Gross Profit
267,663
-43.94%
477,481
N/A
Sales and Marketing Expense
133,999
-64.03%
372,553
N/A
Research and Development Expense
-49,680
-87.29%
-390,828
N/A
Depreciation and Amortization Expense
12,404
+48.57%
8,349
N/A
Total Operating Expenses
2.6M
-81.05%
13.5M
N/A
Operating Profit
-2.3M
-82.41%
-13.0M
N/A
Interest Income
1,501
-95.83%
36,000
N/A
Interest Expense
-115,325
+43.65%
-80,283
N/A
Interest Income and Expense and Net
-113,824
+157.04%
-44,283
N/A
Total Nonoperating Income and Expense
-94,326
+1,961.77%
-4,575
N/A
Income before Taxes
-2.4M
-81.70%
-13.0M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-2.4M
-81.70%
-13.0M
N/A
Net Income from Continuing Operations Applicable to Common
-2.4M
-81.70%
-13.0M
N/A
Basic EPS and Net Income
-0.002
-86.67%
-0.01
N/A
Diluted EPS and Net Income
-0.002
-86.67%
-0.01
N/A
Basic Weighted Average Shares
1.5B
+41.41%
1.1B
N/A
Diluted Weighted Average Shares
1.5B
+41.41%
1.1B
N/A
Balance Sheet
Cash and Cash Equivalents
136,151
+93.11%
70,505
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
136,151
+93.11%
70,505
N/A
Total Current Assets
152,327
-48.78%
297,409
N/A
Accumulated Depreciation
106,343
+13.21%
93,938
N/A
Property and Plant and Equipment and Net
38,689
-7.11%
41,651
N/A
Total Long-Term Assets
38,689
-7.11%
41,651
N/A
Total Assets
223,173
-34.18%
339,060
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
795,833
-18.84%
980,599
N/A
Total Current Liabilities
3.8M
+55.55%
2.4M
N/A
Total Long-Term Debt
673,750
0.00%
673,750
N/A
Total Long-Term Liabilities
18,468
N/A
N/A
N/A
Total Liabilities
3.8M
+56.31%
2.4M
N/A
Retained Earnings
-41.8M
+6.06%
-39.4M
N/A
Total Stockholders Equity
-3.6M
+70.97%
-2.1M
N/A
Total Shares Outstanding
1.6B
+4.90%
1.5B
N/A
Cash Flow
Cash from Operating Activities
-1.3M
-58.82%
-3.1M
N/A
Capital Expenditures
9,442
-81.12%
50,000
N/A
Cash from Investing Activities
-9,442
-81.12%
-50,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.4M
-43.09%
2.4M
N/A
Financials Ratio
Gross Margin
35.92%
N/A
N/A
N/A
Operating Margin
-307.90%
N/A
N/A
N/A
Return on Assets
-849.64%
N/A
N/A
N/A
Return on Equity
84.26%
N/A
N/A
N/A
Revenue Growth
-28.76%
N/A
N/A
N/A
Current Ratio
0.04
N/A
N/A
N/A
Cash Ratio
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.41
N/A
N/A
N/A
Debt-to-Assets Ratio
6.58
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow